Animal vaccine R&D company, Prommune, moving to Kansas City


Prommune, an animal vaccine R&D company, said it's moving its operations from Nebraska to the Kansas City region.

The company, which has been around for more than a decade, plans to expand from its current two employees by adding four to 6 new employees in the next half-year, Sam Al-Murrani, its interim CEO, said in a press release. In the next three years, Prommune is looking to increase its employee count to 12 to 16 positions as it ramps up its clinical process.

Previously based at the University of Nebraska, Omaha, medical center, the company negotiated a licensing agreement with the university for the intellectual property, the Kansas City Business Journal reported. Prommune had been funded by grants that included the National Institutes of Health and the federal Small Business Innovation Research program.

Prommune joins more than 300 like companies that have located operations in what is marketed as the Kansas City Animal Health Corridor, which is defined as a region that spans from Columbia, MO, to Manhattan, KS.

"The Corridor provides unsurpassed logistics, manufacturing and a pool of potential qualified employee mix that a company focused on animal health can ill-afford to ignore," Al-Murrani said in a statement.

- read the KCBJ story